Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07401472
PHASE1

Study of BW-50218 in Healthy Participants

Sponsor: Shanghai Argo Biopharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

Phase 1, Single Ascending Dose Study of Subcutaneous BW-50218 in Healthy Participants

Official title: A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered BW-50218 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

60

Start Date

2026-02-25

Completion Date

2027-06-30

Last Updated

2026-03-05

Healthy Volunteers

Yes

Interventions

DRUG

BW-50218 Injection

Solution for injection

DRUG

Saline (0.9% NaCl)

Solution for injection

Locations (2)

CMAX Clinical Research Pty Ltd

Adelaide, South Australia, Australia

Linear Early Fhase Limited

Nedlands, Western Australia, Australia